NCT06171308

Brief Summary

Type of study:clinical trial Purpose of research:To explore the efficacy and safety of moxibustion combined with Traditional Chinese and Western medicine in treating insomnia. Describe participant population/health conditions:120 insomnia patients

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

October 18, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 14, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

December 14, 2023

Status Verified

October 1, 2023

Enrollment Period

2 years

First QC Date

October 18, 2023

Last Update Submit

December 6, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • The score of PSQI

    The reduction rate of PSQI scale ≥25% was regarded as effective, and the difference between the two groups was compared as the basis for evaluating the main therapeutic effect indicators. The efficacy of insomnia symptoms was evaluated by the difference in the reduction rate of PSQI scores between the two groups before and after the intervention.

    Baseline, week two, week four, week eight

Secondary Outcomes (4)

  • The score of Quality of Life Scale (SQLS)

    Baseline, week two, week four, week eight

  • The score of SF-36 scale

    Baseline, week two, week four, week eight

  • The score of Clinical Gross Impression Scale (CGI)

    Baseline, week two, week four, week eight

  • adverse reaction(TESS)evaluation

    Baseline, week two, week four, week eight

Study Arms (2)

The study group(using the moxibustion)

ACTIVE COMPARATOR

The study group was treated with traditional Chinese moxibustion and western medicine. The control group was treated with blank moxibustion and western medicine. 1. The study group: Using the moxibustion, select specific 3 groups of acupoints. Select a group of acupuncture points every day, in the moxibustion treatment for 20 minutes, 4 weeks for a course of treatment. 2. The control group: Using the moxibustion with blank patch, select specific 3 groups of acupoints. Select a group of acupuncture points every day, in the moxibustion treatment for 20 minutes, 4 weeks for a course of treatment. 3. The treatment period is 4 weeks, which is a course of treatment, and the observation period is 8 weeks.

Device: Traditional Chinese moxibustion apparatus

The control group(using the moxibustion with blank patch)

PLACEBO COMPARATOR

The study group was treated with traditional Chinese moxibustion and western medicine. The control group was treated with blank moxibustion and western medicine. 1. The study group: Using the moxibustion, select specific 3 groups of acupoints. Select a group of acupuncture points every day, in the moxibustion treatment for 20 minutes, 4 weeks for a course of treatment. 2. The control group: Using the moxibustion with blank patch, select specific 3 groups of acupoints. Select a group of acupuncture points every day, in the moxibustion treatment for 20 minutes, 4 weeks for a course of treatment. 3. The treatment period is 4 weeks, which is a course of treatment, and the observation period is 8 weeks.

Device: Traditional Chinese moxibustion apparatus

Interventions

The study group was treated with traditional Chinese moxibustion and western medicine. The control group was treated with blank moxibustion and western medicine. 1. The study group: Using the moxibustion, select specific 3 groups of acupoints. Select a group of acupuncture points every day, in the moxibustion treatment for 20 minutes, 4 weeks for a course of treatment. 2. The control group: Using the moxibustion with blank patch, select specific 3 groups of acupoints. Select a group of acupuncture points every day, in the moxibustion treatment for 20 minutes, 4 weeks for a course of treatment. 3. The treatment period is 4 weeks, which is a course of treatment, and the observation period is 8 weeks.

The control group(using the moxibustion with blank patch)The study group(using the moxibustion)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Meet the diagnostic criteria of ICD-10 insomnia;
  • In line with the relevant diagnostic criteria of TCM syndrome differentiation of heart-spleen and deficiency type insomnia (TCM syndrome diagnosis criteria according to the 1993 Ministry of Health "Guidelines for Clinical Research on the treatment of Insomnia with new Chinese Medicine" standards: heart-spleen and deficiency: palpitation, amnesia, dizziness, poor and tired, pale face, easy to sweat, tongue, thin coat, thin pulse);
  • Pittsburgh Sleep Quality Index (PSQI) score \> 7 at baseline;
  • The treatment plan used in this study is tolerable, cooperative and compliant;
  • Regardless of gender, age 18-65 years old;
  • Understand the procedure and content of the test, and voluntarily sign the informed consent;

You may not qualify if:

  • Participating in other clinical studies;
  • Exclude patients with serious physical diseases or diseases that may affect the evaluation of the test;
  • there is a clear risk of suicide or danger to oneself or others;
  • Exclude pregnant or lactating women, or those planning pregnancy;
  • Persons with alcohol and drug dependence within 1 year prior to screening.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

moxibustion equipment(Zhongshan Jiaxun medical equipment Co., LTD)

Shanghai, Shanghai Municipality, China

RECRUITING

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Central Study Contacts

JING Cai, Undergraduate

CONTACT

JianMing Zhang, graduate student

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 18, 2023

First Posted

December 14, 2023

Study Start

January 1, 2023

Primary Completion

December 31, 2024

Study Completion

December 31, 2025

Last Updated

December 14, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations